Pfizer’s Xeljanz is now approved for the treatment of adults with active ankylosing spondylitis who have had an inadequate response or intolerance to one or more tumor necrosis factor blockers.
The National Association of Chain Drug Stores, National Community Pharmacists Association and American Pharmacists Association commended the Biden administration for initiating action to rein in DIR fees.
More than 1,700 safes have been installed since the beginning of 2020, in an effort to prevent crime and secure controlled substances, the company said.
The Specialty Pharmacy Service Excellence Award is reserved for an industry professional who is not a pharmacist but has demonstrated a commitment to delivering high-quality service and care to patients.
